High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes

Por Cheng, C-L, Hou, H-A, Jhuang, J-Y, Lin, C-W, Chen, C-Y, Tang, J-L, Chou, W-C, Tseng, M-H, Yao, M, Huang, S-Y, Ko, B-S, Hsu, S-C, Wu, S-J, Tsay, W, Chen, Y-C, Tien, H-F
Publicado em 2011

Clinico-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemia

Por Hou, H-A, Lu, J-W, Lin, T-Y, Tsai, C-H, Chou, W-C, Lin, C-C, Kuo, Y-Y, Liu, C-Y, Tseng, M-H, Chiang, Y-C, Peng, Y-L, Tang, J-L, Gong, Z, Lin, L-I, Tien, H-F
Publicado no Blood Cancer J (2017)

Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome

Por Chen, T-C, Hou, H-A, Chou, W-C, Tang, J-L, Kuo, Y-Y, Chen, C-Y, Tseng, M-H, Huang, C-F, Lai, Y-J, Chiang, Y-C, Lee, F-Y, Liu, M-C, Liu, C-W, Liu, C-Y, Yao, M, Huang, S-Y, Ko, B-S, Hsu, S-C, Wu, S-J, Tsay, W, Chen, Y-C, Tien, H-F
Publicado em 2014

TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution

Por Hou, H-A, Chou, W-C, Kuo, Y-Y, Liu, C-Y, Lin, L-I, Tseng, M-H, Chiang, Y-C, Liu, M-C, Liu, C-W, Tang, J-L, Yao, M, Li, C-C, Huang, S-Y, Ko, B-S, Hsu, S-C, Chen, C-Y, Lin, C-T, Wu, S-J, Tsay, W, Chen, Y-C, Tien, H-F
Publicado no Blood Cancer J (2015)